Price target
433.790.000.00%
The 25 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 31 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
DUL EPS for the last quarter is 1.57 EUR despite the estimation of 0.48 EUR. In the next quarter EPS is expected to reach 1.10 EUR. Track more of Alnylam Pharmaceuticals, Inc financials and stay on top of what is up with the company.
In the next quarter Alnylam Pharmaceuticals, Inc revenue is expected to reach 993.79 M EUR. Check out Alnylam Pharmaceuticals, Inc revenue and earnings and make informed decisions.
According to analysts, DUL price target is 433.79 EUR with a max estimate of 501.91 EUR and a min estimate of 320.18 EUR. Check if this forecast comes true in a year, meanwhile watch Alnylam Pharmaceuticals, Inc stock price chart and keep track of the current situation with DUL news and stock market news.
We've gathered opinions of 31 analysts rating DUL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.